Schedule 13D ownership disclosure

NUO THERAPEUTICS INC

Security class unavailable · CUSIP: 67059V209

Event date: 2020-10-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
18.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-22-016503
Form type
SC 13D/A
Filer
Nuo Therapeutics, Inc.
CIK
CIK 1091596
Filed
Jul 05, 2022
Reporting period
Oct 05, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub